CRISPR: how to unlock the genetic technology's potential

A handpicked article read aloud from the latest issue of The Economist. CRISPR, a tool for genetic editing, holds immense promise for medicine and agriculture. But getting the most out of it will require new science and a better system of regulation. Listen to what matters most, from global politics and business to science and technology—subscribe to Economist Podcasts+. For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.